Search

Your selection

None

Filter by content type

Filter by content year

News

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

October 20, 2025 - … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation:   Presentation … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation:   Presentation … 19-22, 2025 , at the Georgia World Congress Center in Atlanta . IDWeek Oral Abstract Presentation:   Presentation …
News

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

News

Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge

News

Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus

March 17, 2023 - … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. degree at the …
News

Vaxart’s S-Only COVID-19 Vaccine Candidate Produces Strong-Cross Reactive Mucosal and Systemic Immune Responses in Non-Human Primates

News

Vaxart Announces Creation of Manufacturing and Quality Advisory Board

September 21, 2021 - … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia.    Vijay Jethwa , Ph.D.     Senior … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia.    Vijay Jethwa , Ph.D.     Senior … an Adjunct Faculty member at Georgia State University in Atlanta , Georgia.    Vijay Jethwa , Ph.D.     Senior …
News

Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset

July 7, 2021 - … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics … a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia . Altesa is developing therapeutics …
News

Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update

News

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

News

Vaxart Hosting Key Opinion Leader Panel Call for Investors

November 16, 2020 - … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University … the Centers for Disease Control and Prevention ( CDC ) in Atlanta, GA. Dr. Vinjé received his Ph.D. at the University …
Scroll to Top